Home/Filings/4/0001209191-22-056573
4//SEC Filing

Magnani John L. 4

Accession 0001209191-22-056573

CIK 0001253689other

Filed

Nov 13, 7:00 PM ET

Accepted

Nov 14, 4:11 PM ET

Size

5.9 KB

Accession

0001209191-22-056573

Insider Transaction Report

Form 4
Period: 2022-11-11
Magnani John L.
DirectorVP of Research, CSO
Transactions
  • Purchase

    Common Stock

    2022-11-11$1.17/sh+45,045$52,703366,078 total
Holdings
  • Common Stock

    (indirect: By GlycoTech Corporation)
    4,845
Footnotes (2)
  • [F1]The Reporting Person purchased the securities on the open market at purchase prices ranging from $1.10 to $1.20 per share, with a weighted average purchase price of $1.17 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
  • [F2]These shares are held by GlycoTech Corporation, of which the reporting person is the sole stockholder.

Issuer

GLYCOMIMETICS INC

CIK 0001253689

Entity typeother

Related Parties

1
  • filerCIK 0001589713

Filing Metadata

Form type
4
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 4:11 PM ET
Size
5.9 KB